Pharmaceutical
-
Eli Lilly: Sleep Apnea Reduced in Last Stage Trials, Zepbound Drug tested
Eli Lilly’s weight-loss medicine Zepbound has been shown to improve obstructive sleep apnea in obese individuals, according to a press…
Read More » -
Ozempic decreased patients’ risk of kidney issues in those with Type 2 diabetes, according to Novo Nordisk
Initial late-stage study data announced on Tuesday showed that Novo Nordisk’s popular medicine Ozempic reduced the risk of kidney disease…
Read More » -
Vertex Achieves Primary Goal in Phase III Trials: Paves the Way for FDA Approval
Vertex Pharmaceuticals’ non-opioid painkiller has accomplished its primary target in late-stage Phase III studies, taking a critical step toward future…
Read More » -
Boots and Walgreens Announce Strategic Store Closures Amid Changing Market Dynamics
Boots and Walgreens, prominent pharmacy chains, are set to close a total of 450 branches across the UK and the…
Read More » -
Roadblocks and checkpoints began using saliva testing to catch drug users
SINGAPORE: At Singapore’s border checkpoints and roadblock operations, saliva tests are now being used to identify drug users, according to…
Read More » -
Changed CRISPR-based catalysts work on the possibility of embedding whole qualities into the genome to defeat different illness causing mutations
Numerous hereditary illnesses are brought about by different transformations spread across a whole quality, and planning genome altering approaches for…
Read More » -
Mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.
Retail pharmacies in the United States will be permitted to sell abortion pills, health officials said Tuesday, a move that…
Read More »
